Jubilant Generics Limited – FDA 483, Aug 1, 2022
Jubilant Generics Limited in Sikanderpur Bhainswal, Uttaranchal, India, was inspected from July 20 to August 1, 2022, and received a Form 483 with six observations. The inspection revealed significant deficiencies in the firm's quality control unit, including failures to thoroughly investigate discrepancies, maintain adequate records for equipment failures and laboratory incidents, and follow established laboratory control mechanisms. Additionally, issues were noted with incomplete batch production and control records, leading to concerns about product quality and data integrity for products shipped to the US market.
ID · 525506c6-0723-4bc0-961f-832821f10990
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.